AlphaGrep UK’s Hims & Hers Health HIMS Stock Holding History

AlphaGrep UK’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,400	Closed	-$278K	–	824
2026 Q1	$278K	Buy	13,400 +6,590	+97%	+$156K	0.08%	549
2025 Q4	$221K	Buy	+6,810	New	+$292K	0.07%	586

Other funds holding HIMS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AlphaGrep UK's HIMS Position: Q2 2026 in Review

AlphaGrep UK sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 13,400 shares — an estimated $278K sold.

AlphaGrep UK first reported a position in HIMS in Q4 2025 and held it in 2 quarters. The position peaked at $278K in Q1 2026. 470 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

AlphaGrep UK reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 13,400 Hims & Hers Health shares in Q2 2026, an estimated $278K.
AlphaGrep UK first reported a position in Hims & Hers Health in Q4 2025 and held it in 2 quarters.
AlphaGrep UK's Hims & Hers Health position peaked at $278K in Q1 2026.
470 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.